Amsterdam UMC Location Vrije Universiteit Amsterdam
OrganisationROR
People
Lead investigator
Lead investigator
Lead investigator
Lead investigator
Lead investigator
Lead investigator
Lead investigator
dr. H.J.M.M. dr. Mutsaerts MD PhD
Lead investigator
Lead investigator
Lead investigator
Lead investigator
Lead investigator
Lead investigator
Lead investigator
Prof. dr. W.M.H. van der Flier
Lead investigator
Sources: openalex.org
Grants and prizes
["Onderzoeksprogramma dementie"], Persoonlijke, Adaptieve, Elektrische Hersenstimulatie Thuis bij beginnende Ziekte van Alzheimer, zonmw-10510032510003-52708, 2026–2029, Lead, 1 Oct 2026
["Onderzoeksprogramma dementie"], Blood based biomarkers for early detection of Alzheimer’s Disease in NCDC, zonmw-10510042320003-44347, 2024–2029, 1 Sept 2024
["Joint Programming Initiative Neurodegenerative Diseases (JPND)"], Prioritization of pathways linking aging and Alzheimer’s disease to cognitive decline and dementia, zonmw-10510062320005-43238, 2024–2027, Lead, 1 Apr 2024
["Veni"], Understanding biological aging: the key towards healthier and happier lives, zonmw-09150162210201-41943, 2024–2027, 14 Feb 2024
["Veni"], Tracing Astrocyte Failure in Alzheimer’s Disease for Precision Prognostics and Therapy Advancement (ASTROIDS-AD), zonmw-09150162210234-41734, 2023–2027, 1 Nov 2023
["Joint Programming Initiative Neurodegenerative Diseases (JPND)"], Crosstalk between exercise and brain lipid metabolism in the protection against Alzheimer’s Disease, zonmw-10510062210007-38933, 2023–2026, Lead, 19 Jun 2023
["ZonMw Open Competitie"], Maintaining intrinsic capacity in an optimal environment to increase healthy ageing: combining population-based data with experiments in a living lab, zonmw-09120012110024-36954, 2023–2028, 1 Jun 2023
["Joint Programming Initiative Neurodegenerative Diseases (JPND)"], Shorter- and longer-term mechanisms of multimodal interventions to prevent dementia, zonmw-10510062210005-37214, 2023–2026, Lead, 1 May 2023
AARF, Can Subtyping of Alzheimer’s Heterogeneity Improve Clinical Trial Design?, 23AARF-1029663, 2023, 1 Jan 2023
["Preventieprogramma 2019-2022"], Informing and supporting hard-to-reach populations from underserved groups in decision-making about cancer screening, zonmw-05550402110012-36887, 2023–2025, 1 Jan 2023
["Off Road"], Dynamic Time Warping to unravel the complexity of changes in physical, cognitive, emotional and social functioning with aging (WARP-AGE), zonmw-04510012110018-37006, 2023–2024, 1 Jan 2023
["InZicht"], ICF Core Set Vision Loss, zonmw-94314003-28510, 2022–2026, Lead, 1 May 2022
["Onderzoeksprogramma dementie"], PAST-AD: Pathogenesis And Spread of Tau in Alzheimer's Disease, zonmw-10510022110010-36905, 2022–2025, Lead, 1 Apr 2022
["Vidi"], Spotlight on the neglected genome to escape dementia, zonmw-09150172010083-36804, 2021–2026, 1 Dec 2021
["Memorabel"], A personalized medicine approach for Alzheimer’s disease (ABOARD), zonmw-73305095007-27409, 2021–2026, Lead, 1 Apr 2021
["Joint Programming Initiative Neurodegenerative Diseases (JPND)"], Developing a non-invasive biomarker for early BBB breakdown in Alzheimer’s disease (DEBBIE), zonmw-733051121-27614, 2021–2025, Lead, 1 Feb 2021
["Vroege opsporing"], Online nurse-assisted eye-screening in home healthcare; implementation study and economic evaluation, from an individual, healthcare and socio-political perspective [iSCREEN-study], zonmw-555004202-26745, 2020–2026, 1 Sept 2020
["Memorabel"], Toepassen van hersennetwerken als maat voor ziektebeloop in de klinische praktijk, zonmw-7330505061-25493, 2020–2022, 10 Jan 2020
["Preventie 5: Deelprogramma 5 - Vroege opsporing"], Risk visualization in personalized breast cancer screening, zonmw-531002033-25014, 2019–2022, 1 May 2019
["Preventie 5: Deelprogramma 5 - Vroege opsporing"], DEVELOPING AND VALIDATING A NEW MEASURE FOR INFORMED DECISION MAKING IN CANCER SCREENING: THE IDMscreen SCALE., zonmw-531002032-25009, 2019–2023, 1 May 2019
Sources: openalex.org